86 related articles for article (PubMed ID: 28620808)
1. Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue.
Kansu-Celik H; Gungor M; Ortac F; Kankaya D; Ensari A
Arch Gynecol Obstet; 2017 Aug; 296(2):313-318. PubMed ID: 28620808
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in papillary serous endometrial carcinoma.
Hosford S; Elliott J; Ma ZW; Majeste R; Dubeshter B
Int J Gynecol Cancer; 2003; 13(4):480-4. PubMed ID: 12911725
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression in curettage and postoperative specimens of endometrial cancer.
Wojciechowski M; Krawczyk T; Śmigielski J; Malinowski A
Arch Gynecol Obstet; 2015 Feb; 291(2):383-90. PubMed ID: 25129125
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
6. Heparanase expression in both normal endometrium and endometrial cancer.
Hasengaowa ; Kodama J; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Int J Gynecol Cancer; 2006; 16(3):1401-6. PubMed ID: 16803537
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.
Saegusa M; Okayasu I
Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker.
Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M
Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468
[TBL] [Abstract][Full Text] [Related]
9. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Al-Maghrabi J; Abdelrahman AS; Ghabrah T; Butt NS; Al-Maghrabi B; Khabaz MN
Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
[TBL] [Abstract][Full Text] [Related]
11. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
12. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
13. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
15. Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.
Avoranta ST; Korkeila EA; Syrjänen KJ; Pyrhönen SO; Sundström JT
World J Gastroenterol; 2012 Sep; 18(33):4549-56. PubMed ID: 22969228
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
17. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
18. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma.
Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W
Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481
[TBL] [Abstract][Full Text] [Related]
20. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]